Caricamento...
Burden of Disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma
BACKGROUND: Isolated limb infusion (ILI) with melphalan is a minimally invasive, effective treatment for in transit melanoma. We hypothesized that burden of disease (BOD) would correlate to treatment response. METHODS: We retrospectively analyzed a prospectively collected database from two academic...
Salvato in:
| Pubblicato in: | Ann Surg Oncol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4505812/ https://ncbi.nlm.nih.gov/pubmed/25192683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-4072-0 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|